发明名称 Injection paradigm for administration of botulinum toxins
摘要 Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
申请公布号 US8968747(B2) 申请公布日期 2015.03.03
申请号 US201313863512 申请日期 2013.04.16
申请人 Allergan, Inc. 发明人 Turkel Catherine C.;Aurora Sheena K.;Brin Mitchell F.
分类号 A61K39/08;A61P25/00;C07K14/33;A61K38/48;A61K9/00 主分类号 A61K39/08
代理机构 代理人 Phan Brigitte C.;Chan Ted A.;Condino Debra
主权项 1. A method for treating or reducing the occurrence of a headache in a patient with chronic migraine headaches, the method consisting essentially of: local administration of a pure botulinum neurotoxin to the frontalis, corrugator, procerus, occipitalis, temporalis, trapezius and cervical paraspinal muscles of the patient that suffers from the migraine headache; wherein the pure botulinum neurotoxin is administered to the frontalis at about twenty units divided among four sites of injection; to the corrugator at about ten units divided among two sites of injection; to the procerus at about five units to one site of injection; to the occipitalis at about thirty units divided among six sites of injection to about forty units divided among eight sites of injection; to the temporalis at about forty units divided among eight sites of injection up to fifty units divided among ten sites of injection; to the trapezius at about thirty units divided among six sites of injection up to about fifty units divided among ten sites of injection and to the cervical paraspinal muscles at about twenty units divided among four sites of injection; wherein the pure botulinum neurotoxin is injected at 31 to 39 injection sites.
地址 Irvine CA US